Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02087046 · ClinicalTrials.gov registry record · NA
Deep Brain Stimulation (DBS) for the Suppression of Tremor
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 127
- Enrollment target
NCT02087046 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 127 participants.
The verdict
NCT02087046, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 127 participants
- Enrollment target
Study Summary
The purpose of the proposed study is to demonstrate the safety and efficacy of the ANS Totally Implantable Deep Brain Stimulation System in the VIM nucleus of the thalamus implanted for the treatment of tremor due to essential tremor. This study will be included in the Pre-Market Approval Application to support the safety of this device in use.
Interventions
- DEVICE ANS Totally Implantable Deep Brain Stimulation System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 127 participants |
| Start Date | 2005-10 |
| Est. Completion | 2017-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02087046
The ClinicalTrials.gov registry entry for NCT02087046 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 127 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ANS Totally Implantable Deep Brain Stimulation System is the first listed.
NCT02087046 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02087046 about?
NCT02087046 is a clinical study titled "Deep Brain Stimulation (DBS) for the Suppression of Tremor". The purpose of the proposed study is to demonstrate the safety and efficacy of the ANS Totally Implantable Deep Brain Stimulation System in the VIM nucleus of the thalamus implanted for the treatment of tremor due to essential tremor. This study will be included in the Pre-Market Approval Applicati...
What is the current status of trial NCT02087046?
This trial is currently completed. It is a NA study. The enrollment target is 127 participants. The study started on 2005-10. Estimated completion is 2017-12.
What interventions are being tested in trial NCT02087046?
The interventions under investigation include: ANS Totally Implantable Deep Brain Stimulation System (DEVICE).
Who is sponsoring clinical trial NCT02087046?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.